￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Oncology

How often should you lose nivolumab

2025-10-19 11:44:20

Check Details
Conditional activation blocks VISTA to inhibit solid tumors, and the US FDA approves the new drug research application of SNS-101

2025-10-19 11:44:20

Check Details
Acting on the tumor microenvironment, Parthenon announced that the self-developed drug PRTH-101 has completed the first patient administration in the phase I clinical trial

2025-10-19 11:44:20

Check Details
Innovent Biologics/Eli Lilly's RET inhibitor "Seputinib" is officially commercialized in China_Canghule

2025-10-19 11:44:20

Check Details
Express delivery! Novartis c-Met inhibitor "capmatinib" applies for marketing in China

2025-10-19 11:44:20

Check Details
The efficacy of nivolumab in treating gastric cancer: is it an immune drug or a targeted drug?

2025-10-19 11:44:20

Check Details
What is the effect of nivolumab combined with chemotherapy? What drug should be used with chemotherapy?

2025-10-19 11:44:20

Check Details
Is gefitinib a targeted drug and is it effective?

2025-10-19 11:44:20

Check Details
What are the indications and pharmacological effects of erlotinib?

2025-10-19 11:44:20

Check Details
Is afatinib effective and how to take it?

2025-10-19 11:44:20

Check Details
Is it necessary to take afatinib for early stage lung cancer? What are the adverse reactions?

2025-10-19 11:44:20

Check Details
Afatinib is a targeted drug of several generations. What diseases does it mainly treat?

2025-10-19 11:44:20

Check Details
Category
相关知识